Tumor-targeted and immune-targeted monoclonal antibodies: Going from passive to active immunotherapy-Reference-Cited by-同舟云学术

Tumor-targeted and immune-targeted monoclonal antibodies: Going from passive to active immunotherapy

Published:2015-03-21 Issue:8 Volume:62 Page:1317-1325
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Marabelle Aurélien¹²,Gray Juliet³

Affiliation:

1. Institut d' Hématologie et d'Oncologie Pédiatrique; Centre de Lutte contre le Cancer Léon Bérard; Lyon France

2. Drug Development Department (DITEP); Gustave Roussy Cancer Campus; Villejuif France

3. Antibody and Vaccine Group, Cancer Research UK Experimental Cancer Medicine Centre; Faculty of Medicine, University of Southampton; Southampton United Kingdom

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25508/fullpdf

Reference82 articles.

1. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody;Miller;New Engl J Med,1982

2. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;Yu;N Engl J Med,2010

3. Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy;Houot;Trends Immunol,2011

4. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma;Weng;J Clin Oncol,2003

5. FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor;Cheung;J Clin Oncol,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer biotherapy: review and prospect;Clinical and Experimental Medicine;2024-05-27

2. Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: a review;Biomedicine & Pharmacotherapy;2022-11

3. Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design and quality control;International Journal of Pharmaceutics;2021-08

4. Antibody-drug conjugates of 7-ethyl-10-hydroxycamptothecin: Sacituzumab govitecan and labetuzumab govitecan;European Journal of Medicinal Chemistry;2019-04

5. French Endocrine Society Guidance on endocrine side effects of immunotherapy;Endocrine-Related Cancer;2019-02